Quick Answer
Tempest Therapeutics, Inc. reported Total Assets of $16.93 million for fiscal year 2025.
Tempest Therapeutics, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $16.93M | -59.2% |
| 2024 | $41.49M | -19.6% |
| 2023 | $51.60M | +12.0% |
| 2022 | $46.09M | -37.1% |
| 2021 | $73.24M | +220.3% |
| 2020 | $22.86M | -69.5% |
| 2019 | $74.97M | -10.8% |
| 2018 | $84.07M | +324.4% |
| 2017 | $19.81M | -83.8% |
| 2016 | $122.54M | -11.6% |
| 2015 | $138.61M | +111.4% |
| 2014 | $65.57M | +37.9% |
| 2013 | $47.55M | +44.9% |
| 2012 | $32.81M | +615.7% |
| 2011 | $4.58M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $17.13M | -49.4% | -30.0% |
| June 30, 2025 | $24.48M | -41.9% | -23.9% |
| March 31, 2025 | $32.16M | -27.5% | -22.5% |
| December 31, 2024 | $41.49M | -19.6% | +22.6% |
| September 30, 2024 | $33.84M | +41.1% | -19.8% |
| June 30, 2024 | $42.17M | +37.2% | -5.0% |
| March 31, 2024 | $44.38M | +18.9% | -14.0% |
| December 31, 2023 | $51.60M | +12.0% | +115.1% |
- Tempest Therapeutics, Inc. showed a decrease of -59.2% in Total Assets compared to the prior fiscal year.
- Over the 2011–2025 period, Tempest Therapeutics, Inc.’s total assets has grown by 269.3% (from $4.58 million to $16.93 million).
- The most recent figure is from Tempest Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: